Moreover, our results indicate potential regulation of DSC1 by NF-κB inhibitor parthenolide as we identified parthenolide to reduce DSC1 protein levels in MCF7 breast cancer cells as well as expression of IGFBP5, LACRT genes and proliferative pathway. Here, NFKB1 is linked to breast carcinoma.